Unique ID issued by UMIN | UMIN000013386 |
---|---|
Receipt number | R000015619 |
Scientific Title | The efficacy of L-Cartin for chronic fatigue syndrome |
Date of disclosure of the study information | 2014/03/20 |
Last modified on | 2017/09/11 17:25:18 |
The efficacy of L-Cartin for chronic fatigue syndrome
The efficacy of L-Cartin for chronic fatigue syndrome
The efficacy of L-Cartin for chronic fatigue syndrome
The efficacy of L-Cartin for chronic fatigue syndrome
Japan |
Chronic fatigue syndrome
Medicine in general |
Others
NO
To investigate an efficacy of taking "L-Cartin" which indicates for carnitine deficiency, for symptoms of chronic fatigue syndrome patients
Efficacy
Chalder Fatigue Scale,Performance
Status, Fatigue sensation : Visual Analog Scale
CES-D, POMS, Autonomic nervous system, Carnitine, Ammonia, arithmetic task, d-ROMs, BAP, sleep-wake cycle, near infrared spectrometer
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Medicine |
L-Cartine FF 10 % (Otsuka Pharmacy, Co.LTD., Japan), 2000 mg / day, 8 weeks
20 | years-old | <= |
60 | years-old | > |
Male and Female
Chronic fatigue syndrome (CFS) patients who visit Osaka City University Hospitals, Fatigue Clinical Center and are eligible for the following criteria.
(1) Patients fulfilling the CFS criteria determined by CDC (1994)
(2) Patients whose diseases duration are more than 6 months and less than 15 years
(3) Patients whose fatigue related performances status are equal or less than 3
(4) Patients who are less than 60 year-old and non-smokers at the time of getting the informed consent
(5) Patients whose body mass index are equal or more than 16 and equal and less than 30 at the time of getting the informed consent
(6) Patients who are capable of understanding the study, and those who can give written informed consents
(1)Patients comorbid with organic diseases which apparently induce fatigue except CFS
(2)During the pregnancy or nursing, or patients to be pregnant during the study period
(3)Patients who receive warfarin
(4)Patients who receive carnitine
(5)Others
60
1st name | |
Middle name | |
Last name | Masaaki Inaba |
Osaka City University, Graduate School of Medicine
Metabolism, Endocrinology and Molecular Medicine
1-5-7, Asahi-machi, Abenoku, Osaka Cit
06-6645-2311
m1356849@med.osaka-cu.ac.jp
1st name | |
Middle name | |
Last name | Hirohiko Kuratsune |
Osaka City University, Graduate School of Medicine
Physiology
1-4-3, Asahi-machi, Abenoku, Osaka City
06-6646-3033
kura@med.osaka-cu.ac.jp
Osaka City University Graduate School of Medicine
outside various funds
Other
Yamaguchi University, Graduate School of Medicine
NO
2014 | Year | 03 | Month | 20 | Day |
Unpublished
No longer recruiting
2014 | Year | 01 | Month | 09 | Day |
2014 | Year | 05 | Month | 01 | Day |
2017 | Year | 08 | Month | 10 | Day |
2017 | Year | 08 | Month | 10 | Day |
2014 | Year | 03 | Month | 10 | Day |
2017 | Year | 09 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015619